SP-420 Dosing Regimen With Recovery Intervals for Iron Overload
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current iron chelators for treating iron overload suffer from significant toxicity and non-compliance issues due to their dosing frequency and mechanism of action, leading to severe side effects, particularly in sensitive organs like the kidney and intestine.
Innovation Solution
A modified dosing regimen for the iron chelator SP-420, administered every other day or with weekend breaks, allows for cellular recovery periods, reducing the frequency of exposure to minimize toxicity while maintaining effective iron removal from the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If iron chelators are administered frequently to maintain effective iron removal, then iron clearance efficacy is improved, but toxicity to sensitive organs increases
Solution Approach 1:
The patent implements periodic dosing regimens with drug-free intervals between treatment cycles. Patients receive iron chelation therapy for specific durations (e.g., 3-5 days) followed by drug-free periods (e.g., 2-7 days), creating a rhythmic pattern of treatment and recovery that allows sensitive organs to regenerate while maintaining overall iron clearance efficacy.
Solution Approach 2:
The patent applies preliminary protective measures before iron chelation therapy by administering protective agents or pre-conditioning treatments that shield sensitive organs from即将到来的 chelation stress. This preparatory action reduces organ vulnerability and enables higher effective dosing with reduced toxicity.
2Productivity
If standard dosing regimens are used to ensure effective iron chelation, then iron removal is improved, but patient compliance deteriorates due to severe side effects
Solution Approach 1:
By structuring treatment as periodic cycles with drug-free intervals, the patent transforms continuous harsh dosing into manageable episodic treatment. This rhythmic approach allows patients to experience treatment benefits while having anticipated recovery periods, significantly improving adherence and reducing dropout rates.
Solution Approach 2:
The patent modifies dosing parameters including frequency, duration, and intensity of treatment cycles. By adjusting these parameters to create fluctuating dose patterns rather than constant dosing, the patent maintains therapeutic effectiveness while reducing cumulative toxicity and improving patient tolerance and compliance.
3Productivity
If continuous iron chelation therapy is administered to maximize iron clearance, then iron overload treatment is improved, but organ recovery time is reduced leading to cumulative damage
Solution Approach 1:
The patent implements periodic dosing regimens with drug-free intervals between treatment cycles. Patients receive iron chelation therapy for specific durations (e.g., 3-5 days) followed by drug-free periods (e.g., 2-7 days), creating a rhythmic pattern of treatment and recovery that allows sensitive organs to regenerate while maintaining overall iron clearance efficacy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This regimen reduces the toxicity associated with iron chelation by allowing sensitive organs to recover from chelation effects, enhancing compliance and minimizing side effects without compromising overall iron clearance.
Implementation Method 1
iron chelators are small molecules that form complexes with iron and promote iron excretion
Data Source
Figure 1A
Figure 1B
Figure 2
AI summary
The present disclosure provides safe and effective dosing regimens of metal chelators as treatment for metal overload disorders and, in particular, iron overload and associated conditions.